FASENRA (Benralizumab)
- Fasenra is a medication for patients with eosinophilic asthma and works by reducing the number of eosinophils in your blood.
- Fasenra is administered as a shot under the skin. It is given once every four weeks for the first three doses, then once every eight weeks.
- After you receive a dose of Fasenra, most infusion centers will monitor you for a period of time to make sure you do not have any reactions to the medication.
- The most common side effects with Fasenra are:
- Headache
- Sore throat
- Severe allergic reaction (Rare)